Thomas E Herman bought $425k of CSQ
VP and CFO at CALAMOS STRATEGIC TOTAL RETURN FUND. 23,190 shares at an average of $18.31, traded Jan 29, 2025, filed Jan 31, 2025.
Score components
- +22RoleCFO
- +16Trade size$425k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -3.5%, 3m -8.4%, 6m +2.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001679182-25-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 29, 2025 | POpen-market purchase Calamos Strategic Total Return Fund | +11,683 | $18.23 | $213k | 11,683 | Jan 31, 2025 |
| Jan 30, 2025 | POpen-market purchase Calamos Strategic Total Return Fund | +11,507 | $18.39 | $212k | 23,190 | Jan 31, 2025 |
Related signals
Other insiders at CALAMOS STRATEGIC TOTAL RETURN FUND and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 47Moderate | CSQsell CALAMOS STRATEGIC TOTAL RETURN FUND | John S. Koudounis Vice President | $190k 13,410 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.